Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionGWX - SPDR(R) S&P(R) International Small Cap ETF
Latest Disclosed Ownership22,820 shares
Latest Disclosed Value $ 207,415
GWX - SPDR(R) S&P(R) International Small Cap ETF reports 1.78% increase in ownership of 4577 / Daito Pharmaceutical Co.,Ltd.

On May 28, 2026 - GWX - SPDR(R) S&P(R) International Small Cap ETF filed a NPORT-P form disclosing ownership of 22,820 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $32,997,720 USD as of March 31, 2026. The entity filed a previous NPORT-P on February 26, 2026 disclosing 22,420 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 1.78% during the quarter. The current value of the position is $30,943,920 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-28 2026-03-31 NP Daito Pharmaceutical EC JP3486150000 22,820 400 1.78 207 7.25 0.0256
2026-02-26 2025-12-31 NP Daito Pharmaceutical EC JP3486150000 22,420 -300 -1.32 194 2.12 0.0246
2025-11-26 2025-09-30 NP Daito Pharmaceutical EC JP3486150000 22,720 4,100 22.02 189 47.66 0.0239
2025-08-28 2025-06-30 NP Daito Pharmaceutical EC JP3486150000 18,620 9,160 96.83 129 -7.25 0.0182
2025-05-28 2025-03-31 NP Daito Pharmaceutical EC JP3486150000 9,460 0 0.00 138 10.40 0.0224
2025-02-27 2024-12-31 NP Daito Pharmaceutical EC JP3486150000 9,460 0 0.00 126 -15.54 0.0202
2024-11-25 2024-09-30 NP Daito Pharmaceutical EC JP3486150000 9,460 0 0.00 149 12.98 0.0215
2024-08-28 2024-06-30 NP Daito Pharmaceutical EC JP3486150000 9,460 0 0.00 131 -9.66 0.0209
2024-05-28 2024-03-31 NP Daito Pharmaceutical EC JP3486150000 9,460 0 0.00 146 14.17 0.0227
2024-02-27 2023-12-31 NP Daito Pharmaceutical EC JP3486150000 9,460 0 0.00 128 -14.19 0.0177
2023-11-28 2023-09-30 NP Daito Pharmaceutical EC JP3486150000 9,460 860 10.00 149 8.82 0.0225
2023-08-28 2023-06-30 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 136 -14.47 0.0196
2023-05-30 2023-03-31 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 159 -1.85 0.0223
2023-02-28 2022-12-31 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 163 10.96 0.0239
2022-11-28 2022-09-30 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 146 -17.05 0.0244
2022-08-26 2022-06-30 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 176 -12.87 0.0271
2022-05-27 2022-03-31 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 203 -8.60 0.0251
2022-02-25 2021-12-31 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 222 -14.67 0.0270
2021-11-26 2021-09-30 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 259 -0.77 0.0313
2021-08-27 2021-06-30 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 261 -6.45 0.0311
2021-05-28 2021-03-31 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 280 -9.71 0.0338
2021-02-26 2020-12-31 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 310 7.29 0.0393
2020-11-19 2020-09-30 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 288 -9.43 0.0415
2020-08-27 2020-06-30 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 318 35.32 0.0489
2020-06-01 2020-03-31 NP Daito Pharmaceutical EC JP3486150000 8,600 0 0.00 235 -2.08 0.0410
2019-11-18 2019-09-30 NP Daito Pharmaceutical EC JP3486150000 8,600 8,600 240 0.0305
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.